机译:耐用的缓解患者,患有Myc / Bcl6阳性双击DLBCL的百分之肌擦伤,用Lenalidomide单药治疗
Department of Diagnostic Clinical and Public Health MedicineUniversity of Modena and Reggio;
Department of Diagnostic Clinical and Public Health MedicineUniversity of Modena and Reggio;
Department of Diagnostic Clinical and Public Health MedicineUniversity of Modena and Reggio;
Department of Diagnostic Clinical and Public Health MedicineUniversity of Modena and Reggio;
Arcispedale Santa Maria Nuova IRCCS Reggio EmiliaUniversity of Modena and Reggio EmiliaModena Italy;
double‐hit lymphoma; lenalidomide; CNS lymphoma;
机译:耐用的缓解患者,患有Myc / Bcl6阳性双击DLBCL的百分之肌擦伤,用Lenalidomide单药治疗
机译:MYC / BCL2 / BCL6三重淋巴瘤:40例患者与MYC / BCL2和MYC / BCL6双重淋巴瘤的比较
机译:小剂量来那度胺治疗的老年急性髓性白血病复发患者的持久临床和细胞遗传学缓解。
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:Piggybac生成的CAR19-T细胞加上Lenalidomide导致耐用的完全缓解Triple-Hit难治性/复发DLBCL:案例报告
机译:同种异体移植在自体移植后复发的一部分DLBCL患者中提供持久的缓解